Find Fosnetupitant Chloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C31H36Cl2F6N4O5P-
Molecular Weight
760.5  g/mol
InChI Key
LBTQUZNIWCWBNN-UHFFFAOYSA-M

Fosnetupitant Chloride
1 2D Structure

Fosnetupitant Chloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[5-[[2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl]-methylamino]-4-(2-methylphenyl)pyridin-2-yl]-1-methylpiperazin-1-ium-1-yl]methyl hydrogen phosphate;chloride;hydrochloride
2.1.2 InChI
InChI=1S/C31H35F6N4O5P.2ClH/c1-20-8-6-7-9-24(20)25-17-27(40-10-12-41(5,13-11-40)19-46-47(43,44)45)38-18-26(25)39(4)28(42)29(2,3)21-14-22(30(32,33)34)16-23(15-21)31(35,36)37;;/h6-9,14-18H,10-13,19H2,1-5H3,(H-,43,44,45);2*1H/p-1
2.1.3 InChI Key
LBTQUZNIWCWBNN-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CC[N+](CC4)(C)COP(=O)(O)[O-].Cl.[Cl-]
2.1.5 Isomeric SMILES
CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CC[N+](CC4)(C)COP(=O)(O)[O-].Cl.[Cl-]
2.2 Create Date
2017-05-28
3 Chemical and Physical Properties
Molecular Weight 760.5 g/mol
Molecular Formula C31H36Cl2F6N4O5P-
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count14
Rotatable Bond Count8
Exact Mass759.1704566 g/mol
Monoisotopic Mass759.1704566 g/mol
Topological Polar Surface Area106 A^2
Heavy Atom Count49
Formal Charge-1
Complexity1100
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 1  
Drug NameAKYNZEO
Active IngredientFOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
CompanyHELSINN HLTHCARE (Application Number: N210493)

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - POWDER;INTRAVENOUS - EQ 235MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL

USFDA APPLICATION NUMBER - 210493

read-more

DOSAGE - SOLUTION;INTRAVENOUS - EQ 235MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)

USFDA APPLICATION NUMBER - 210493

read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Fosnetupitant Chloride Manufacturers

A Fosnetupitant Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosnetupitant Chloride, including repackagers and relabelers. The FDA regulates Fosnetupitant Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosnetupitant Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Fosnetupitant Chloride Suppliers

A Fosnetupitant Chloride supplier is an individual or a company that provides Fosnetupitant Chloride active pharmaceutical ingredient (API) or Fosnetupitant Chloride finished formulations upon request. The Fosnetupitant Chloride suppliers may include Fosnetupitant Chloride API manufacturers, exporters, distributors and traders.

click here to find a list of Fosnetupitant Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Fosnetupitant Chloride USDMF

A Fosnetupitant Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosnetupitant Chloride active pharmaceutical ingredient (API) in detail. Different forms of Fosnetupitant Chloride DMFs exist exist since differing nations have different regulations, such as Fosnetupitant Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Fosnetupitant Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. Fosnetupitant Chloride USDMF includes data on Fosnetupitant Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosnetupitant Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Fosnetupitant Chloride suppliers with USDMF on PharmaCompass.

Fosnetupitant Chloride JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Fosnetupitant Chloride Drug Master File in Japan (Fosnetupitant Chloride JDMF) empowers Fosnetupitant Chloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Fosnetupitant Chloride JDMF during the approval evaluation for pharmaceutical products. At the time of Fosnetupitant Chloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Fosnetupitant Chloride suppliers with JDMF on PharmaCompass.

Fosnetupitant Chloride KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Fosnetupitant Chloride Drug Master File in Korea (Fosnetupitant Chloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fosnetupitant Chloride. The MFDS reviews the Fosnetupitant Chloride KDMF as part of the drug registration process and uses the information provided in the Fosnetupitant Chloride KDMF to evaluate the safety and efficacy of the drug.

After submitting a Fosnetupitant Chloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fosnetupitant Chloride API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Fosnetupitant Chloride suppliers with KDMF on PharmaCompass.

Fosnetupitant Chloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosnetupitant Chloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Fosnetupitant Chloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Fosnetupitant Chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Fosnetupitant Chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosnetupitant Chloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Fosnetupitant Chloride suppliers with NDC on PharmaCompass.

Fosnetupitant Chloride GMP

Fosnetupitant Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Fosnetupitant Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosnetupitant Chloride GMP manufacturer or Fosnetupitant Chloride GMP API supplier for your needs.

Fosnetupitant Chloride CoA

A Fosnetupitant Chloride CoA (Certificate of Analysis) is a formal document that attests to Fosnetupitant Chloride's compliance with Fosnetupitant Chloride specifications and serves as a tool for batch-level quality control.

Fosnetupitant Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Fosnetupitant Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Fosnetupitant Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosnetupitant Chloride EP), Fosnetupitant Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosnetupitant Chloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty